Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Mon 22 Jul 2019, 10:00 ASCENDIS HEALTH LIMITED - Further cautionary announcement
ASC 201907220014A
Further cautionary announcement

Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
ISIN: ZAE000185005
("Ascendis Health" or "the Company")

Further cautionary announcement

Shareholders are referred to the previous cautionary and subsequent renewals thereof, the
latest being done on 7 June 2019 as published on SENS, relating to an unsolicited offer
received for the Remedica business unit ("Remedica") in Cyprus. Ascendis Health is involved
in ongoing negotiations regarding the potential disposal of Remedica and will update investors
should a transaction be concluded.

Shareholders are advised to continue to exercise caution when dealing in the Company's
securities until a further announcement is made.

22 July 2019
Johannesburg


Sponsor
Questco Corporate Advisory Proprietary Limited

Date: 22/07/2019 10:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: